Abstract
Aim:We examined the utility of the rs924607 TT genotype of the centrosomal protein 72 (CEP72) as a potential biomarker for predilection toward vincristine-induced peripheral neuropathy in children treated for acute lymphoblastic leukemia.Materials & methods:We conducted a random-effects meta-analysis of data from four studies comprising 817 patients. We tested for an association using a recessive model where a one-sided p-value < 0.05 was considered statistically significant.Results & conclusion:We were unable to confirm the association between the rs924607 TT genotype and neurotoxicity (odds ratio: 1.99; p = 0.16; 95% CI: 0.76–5.25) in our global meta-analysis. Analysis of the continuation phase (following induction) studies showed significantly higher odds for neuropathy in CEP72 rs924607 TT homozygotes (odds ratio: 2.28; p = 0.02; 95% CI: 1.16–6.87).
Highlights
We were unable to confirm the association between the CEP72 rs924607 TT genotype and neurotoxicity in our global meta-analysis
Our meta-analysis is the first validation of the association between the CEP72 rs924607 TT genotype and vincristine-induced peripheral neuropathy exclusively in pediatric patients
This may be the reason why the results differ
Summary
We examined the utility of the rs924607 TT genotype of the centrosomal protein 72 (CEP72) as a potential biomarker for predilection toward vincristine-induced peripheral neuropathy in children treated for acute lymphoblastic leukemia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have